Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone for Oral Leukoplakia
NCT00369174Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2006
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rosiglitazone in oral leukoplakia, sponsored by National Cancer Institute. Started Jun 2006; status: completed.
02
Drugs
rosiglitazone
03
Conditions
oral leukoplakia
Beyond the preview
Go deeper on NCT00369174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00369174.